Welcome to our dedicated page for Panacea Life Sciences Hldgs news (Ticker: PLSH), a resource for investors and traders seeking the latest updates and insights on Panacea Life Sciences Hldgs stock.
Panacea Life Sciences Holdings, Inc. (PLSH) generates news across multiple areas of the natural health and wellness industry, reflecting its role as a holding company for plant-based ingredient and product businesses. Company announcements cover developments in nutraceuticals, cannabinoid products, functional mushrooms, kratom, kava, and other natural health offerings for humans and animals, as well as updates on research, retail expansion and distribution partnerships.
News items frequently highlight Panacea’s manufacturing and research activities at its cGMP facility in Golden, Colorado, including clinical and open-label studies involving CBD/CBG formulations and collaborations with academic institutions on mushroom analytics and dietary supplement trials. Investors and observers can find updates on how these efforts support the company’s goal of addressing unmet needs in health and wellness through plant-based ingredients.
Panacea’s news flow also includes coverage of acquisitions and agreements that extend its presence into natural health and wellness retail chains, franchise models and distribution networks. Examples include transactions involving retail locations in the Tampa, Florida area, the PÜR LIFE Medical franchise, and a Letter of Intent related to Sierra Sage Herbs and Halucenex. These stories illustrate how the company is pursuing a vertically integrated approach spanning manufacturing, branded products, clinics and retail outlets.
In addition, Panacea reports on licensing and distribution relationships, such as its agreement with Sky Wellness for CBD product marketing and development and its exclusive distribution agreement with QR Joy to distribute Fume disposable vape devices in the U.K. More recently, the launch of Benivita PLSH has introduced news related to a direct-to-consumer telemedicine and non-insurance benefits platform. Readers interested in PLSH can use this news page to follow the company’s evolving activities in natural health products, alternative therapies, retail expansion and telemedicine-based benefits.
Panacea Life Sciences, Inc. (OTCQB:PLSH) has partnered with MyPharma2Go to enter Brazil's cannabis market. This collaboration aims to enhance MyPharma2Go's offerings by delivering premium cannabis products. Founded in 2017, MyPharma2Go has supported over 240,000 patients across Brazil. According to their CEO, the partnership aligns with their goal of top-tier service. Panacea's Executive VP, Nick Cavarra, stated that this partnership provides access to Brazil's large consumer base, potentially increasing revenues and shareholder value in 2022.
Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) announced the closure of a private placement with Lincoln Park Capital Fund, LLC, raising $1 million. The transaction involved a 10% original issue discount senior convertible promissory note worth $1.1 million and warrants to buy 785,715 shares at a $1.40 exercise price. This funding aims to enhance growth strategies and market share for Panacea's cannabinoid products. The company operates a 51,000 square foot facility in Colorado and has secured prior investments totaling $34 million.
Exactus, Inc. (OTCQB:EXDI), soon to be Panacea Life Sciences, Inc. (OTCQB:PLSH), is leveraging the resurgence of air travel at Denver International Airport (DEN), which saw nearly 25 million passengers in the first half of 2021. Panacea is the first company to sell CBD products at DEN, offering over 18 therapeutic products designed to alleviate travel-related discomfort. These products comply with legal standards, containing less than 0.3% THC. Panacea, founded in 2017, has received $20 million in investments and operates a 51,000 sq. ft. certified facility in Colorado.
Exactus, Inc. (OTCQB:EXDI), soon to be Panacea Life Sciences, Inc. (OTCQB:PLSH), is leveraging the resurgence of passenger traffic at Denver International Airport to promote its premium CBD products, with nearly 25 million travelers in the first half of 2021. Panacea has established two kiosk locations in the airport, making it the first company to offer CBD products directly to passengers. The range includes topical CBD items for pain relief, adhering to hemp regulations. Founded in 2017, Panacea has attracted $20 million in investments, continuing to grow in the evolving CBD market.